The Rubinstein-Taybi syndrome: Modeling mental impairment in the mouse

Genes, Brain and Behavior

Volumn 6, Issue SUPPL. 1, 2007, Pages 32-39

  Barco, A ^a  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

CREB binding protein; Mental impairment; Mouse model; Rubinstein Taybi syndrome

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HT 0712; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM; UNCLASSIFIED DRUG; VORINOSTAT;

COGNITIVE DEFECT; COMPARATIVE STUDY; DEVELOPMENT; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; INCIDENCE; MEMORY; MENTAL DISEASE; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RUBINSTEIN SYNDROME; TRANSCRIPTION INITIATION;

ANIMALS; CREB-BINDING PROTEIN; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; RUBINSTEIN-TAYBI SYNDROME;

ANIMALIA;

EID: 34248340376     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2007.00320.x     Document Type: Review

References (60)

1. Alarcon, J.M., Malleret, G., Touzani, K., Vronskaya, S., Ishii, S., Kandel, E.R. Barco, A 2004) Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42, 947 959.
2. Bannister, A.J., Oehler, T., Wilhelm, D., Angel, P. Kouzarides, T 1995) Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11, 2509 2514.
3. Barad, M., Bourtchouladze, R., Winder, D.G., Golan, H. Kandel, E 1998) Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci USA 95, 15020 15025.
4. Barco, A., Pittenger, C. Kandel, E.R 2003) CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin Ther Targets 7, 101 114.
5. Bourtchouladze, R., Lidge, R., Catapano, R., Stanley, J., Gossweiler, S., Romashko, D., Scott, R. Tully, T 2003) A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc Natl Acad Sci USA 100, 10518 10522.
6. Boyes, J., Byfield, P., Nakatani, Y. Ogryzko, V 1998) Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396, 594 598.
7. Branchi, I. Ricceri, L 2002) Transgenic and knock-out mouse pups: the growing need for behavioral analysis. Genes Brain Behav 1, 135 141.
8. Chan, H.M., Krstic-Demonacos, M., Smith, L., Demonacos, C. La Thangue, N.B 2001) Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 3, 667 674.
9. Chrivia, J.C., Kwok, R.P., Lamb, N., Hagiwara, M., Montminy, M.R. Goodman, R.H 1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855 859.
10. Coupry, I., Roudaut, C., Stef, M., Delrue, M.A., Marche, M., Burgelin, I., Taine, L., Cruaud, C., Lacombe, D. Arveiler, B 2002) Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome. J Med Genet 39, 415 421.
11. Ferrante, R.J., Kubilus, J.K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N.W., Ratan, R.R., Luthi-Carter, R. Hersch, S.M 2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23, 9418 9427.
12. Gerritsen, M.E., Williams, A.J., Neish, A.S., Moore, S., Shi, Y. Collins, T 1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94, 2927 2932.
13. Gotts, E.E. Liemohn, W.P 1977) Behavioral characteristics of three children with the broad thumb-hallux (Rubinstein-Taybi) syndrome. Biol Psychiatry 12, 413 423.
14. Gu, W. Roeder, R.G 1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595 606.
15. Hallam, T.M. Bourtchouladze, R 2006) Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction. Cell Mol Life Sci 63, 1725 1735.
16. Hennekam, R.C., Baselier, A.C., Beyaert, E., Bos, A., Blok, J.B., Jansma, H.B., Thorbecke-Nilsen, V.V. Veerman, H 1992) Psychological and speech studies in Rubinstein-Taybi syndrome. Am J Ment Retard 96, 645 660.
17. Hockly, E., Richon, V.M., Woodman, B., Smith, D.L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P.A., Steffan, J.S., Marsh, J.L., Thompson, L.M., Lewis, C.M., Marks, P.A. Bates, G.P 2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA 100, 2041 2046.
18. Hung, H.L., Kim, A.Y., Hong, W., Rakowski, C. Blobel, G.A 2001) Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation. J Biol Chem 276, 10715 10721.
19. Impey, S., Fong, A.L., Wang, Y., Cardinaux, J.R., Fass, D.M., Obrietan, K., Wayman, G.A., Storm, D.R., Soderling, T.R. Goodman, R.H 2002) Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron 34, 235 244.
20. Janknecht, R 2002) The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease. Histol Histopathol 17, 657 668.
21. Janknecht, R. Nordheim, A 1996) MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP. Biochem Biophys Res Commun 228, 831 837.
22. Josselyn, S.A 2005) What's right with my mouse model? New insights into the molecular and cellular basis of cognition from mouse models of Rubinstein-Taybi Syndrome. Learn Mem 12, 80 83.
23. Kalkhoven, E 2004) CBP and p300: HATs for different occasions. Biochem Pharmacol 68, 1145 1155.
24. Kalkhoven, E., Roelfsema, J.H., Teunissen, H., den Boer, A., Ariyurek, Y., Zantema, A., Breuning, M.H., Hennekam, R.C. Peters, D.J 2003) Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. Hum Mol Genet 12, 441 450.
25. Kandel, E.R 2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030 1038.
26. Kang-Decker, N., Tong, C., Boussouar, F., Baker, D.J., Xu, W., Leontovich, A.A., Taylor, W.R., Brindle, P.K. van Deursen, J.M 2004) Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. Cancer Cell 5, 177 189.
27. Kasper, L.H., Boussouar, F., Ney, P.A., Jackson, C.W., Rehg, J., van Deursen, J.M. Brindle, P.K 2002) A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature 419, 738 743.
28. Korzus, E., Torchia, J., Rose, D.W., Xu, L., Kurokawa, R., McInerney, E.M., Mullen, T.M., Glass, C.K. Rosenfeld, M.G 1998) Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279, 703 707.
29. Korzus, E., Rosenfeld, M.G. Mayford, M 2004) CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42, 961 972.
30. Kouraklis, G. Theocharis, S 2002) Histone deacetylase inhibitors and anticancer therapy. Curr Med Chem Anti-Canc Agents 2, 477 484.
31. Kung, A.L., Rebel, V.I., Bronson, R.T., Ch'ng, L.E., Sieff, C.A., Livingston, D.M. Yao, T.P 2000) Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev 14, 272 277.
32. Levenson, J.M., O'Riordan, K.J., Brown, K.D., Trinh, M.A., Molfese, D.L. Sweatt, J.D 2004) Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 279, 40545 40559.
33. Levine, A.A., Guan, Z., Barco, A., Xu, S., Kandel, E.R. Schwartz, J.H 2005) CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci USA 102, 19186 19191.
34. Liu, L., Scolnick, D.M., Trievel, R.C., Zhang, H.B., Marmorstein, R., Halazonetis, T.D. Berger, S.L 1999) p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19, 1202 1209.
35. Martin, S.J., Grimwood, P.D. Morris, R.G 2000) Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci 23, 649 711.
36. Mayford, M., Bach, M.E., Huang, Y.Y., Wang, L., Hawkins, R.D. Kandel, E.R 1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274, 1678 1683.
37. McLaughlin, F. La Thangue, N.B 2004) Histone deacetylase inhibitors open new doors in cancer therapy. Biochem Pharmacol 68, 1139 1144.
38. Murata, T., Kurokawa, R., Krones, A., Tatsumi, K., Ishii, M., Taki, T., Masuno, M., Ohashi, H., Yanagisawa, M., Rosenfeld, M.G., Glass, C.K. Hayashi, Y 2001) Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum Mol Genet 10, 1071 1076.
39. Myers, F.A., Chong, W., Evans, D.R., Thorne, A.W. Crane-Robinson, C 2003) Acetylation of histone H2B mirrors that of H4 and H3 at the chicken beta-globin locus but not at housekeeping genes. J Biol Chem 278, 36315 36322.
40. Oike, Y., Hata, A., Mamiya, T., Kaname, T., Noda, Y., Suzuki, M., Yasue, H., Nabeshima, T., Araki, K. Yamamura, K 1999a) Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum Mol Genet 8, 387 396.
41. Oike, Y., Takakura, N., Hata, A., Kaname, T., Akizuki, M., Yamaguchi, Y., Yasue, H., Araki, K., Yamamura, K. Suda, T 1999b) Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 93, 2771 2779.
42. Parker, D., Ferreri, K., Nakajima, T., LaMorte, V.J., Evans, R., Koerber, S.C., Hoeger, C. Montminy, M.R 1996) Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol 16, 694 703.
43. Perkins, N.D., Felzien, L.K., Betts, J.C., Leung, K., Beach, D.H. Nabel, G.J 1997) Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523 527.
44. Petrij, F., Giles, R.H., Dauwerse, H.G., Saris, J.J., Hennekam, R.C., Masuno, M., Tommerup, N., van Ommen, G.J., Goodman, R.H., Peters, D.J. Breuning, M.H 1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348 351.
45. Petrij, F., Dauwerse, H.G., Blough, R.I., Giles, R.H., van der Smagt, J.J., Wallerstein, R., Maaswinkel-Mooy, P.D., van Karnebeek, C.D., van Ommen, G.J., van Haeringen, A., Rubinstein, J.H., Saal, H.M., Hennekam, R.C., Peters, D.J. Breuning, M.H 2000) Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations. J Med Genet 37, 168 176.
46. Roelfsema, J.H., White, S.J., Ariyurek, Y., Bartholdi, D., Niedrist, D., Papadia, F., Bacino, C.A., den Dunnen, J.T., van Ommen, G.J., Breuning, M.H., Hennekam, R.C. Peters, D.J 2005) Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 76, 572 580.
47. Rubinstein, J.H. Taybi, H 1963) Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 105, 588 608.
48. Tanaka, Y., Naruse, I., Maekawa, T., Masuya, H., Shiroishi, T. Ishii, S 1997) Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. Proc Natl Acad Sci USA 94, 10215 10220.
49. Tanaka, Y., Naruse, I., Hongo, T., Xu, M., Nakahata, T., Maekawa, T. Ishii, S 2000) Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein. Mech Dev 95, 133 145.
50. Watase, K. Zoghbi, H.Y 2003) Modelling brain diseases in mice: the challenges of design and analysis. Nat Rev Genet 4, 296 307.
51. Wiley, S., Swayne, S., Rubinstein, J.H., Lanphear, N.E. Stevens, C.A 2003) Rubinstein-Taybi syndrome medical guidelines. Am J Med Genet A 119, 101 110.
52. Wood, M.A., Kaplan, M.P., Park, A., Blanchard, E.J., Oliveira, A.M., Lombardi, T.L. Abel, T 2005) Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. Learn Mem 12, 111 119.
53. Wood, M.A., Attner, M.A., Oliveira, A.M., Brindle, P.K. Abel, T 2006) A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes. Learn Mem 13, 609 617.
54. Xu, W., Chen, H., Du, K., Asahara, H., Tini, M., Emerson, B.M., Montminy, M. Evans, R.M 2001) A transcriptional switch mediated by cofactor methylation. Science 294, 2507 2511.
55. Yamauchi, T., Oike, Y., Kamon, J., Waki, H., Komeda, K., Tsuchida, A., Date, Y., Li, M.X., Miki, H., Akanuma, Y., Nagai, R., Kimura, S., Saheki, T., Nakazato, M., Naitoh, T., Yamamura, K. Kadowaki, T 2002) Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nat Genet 30, 221 226.
56. Yao, T.P., Oh, S.P., Fuchs, M., Zhou, N.D., Ch'ng, L.E., Newsome, D., Bronson, R.T., Li, E., Livingston, D.M. Eckner, R 1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361 372.
57. Yeh, S.H., Lin, C.H. Gean, P.W 2004) Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory. Mol Pharmacol 65, 1286 1292.
58. Zanger, K., Radovick, S. Wondisford, F.E 2001) CREB binding protein recruitment to the transcription complex requires growth factor-dependent phosphorylation of its GF box. Mol Cell 7, 551 558.
59. Zhang, M.M., Xiao, C., Yu, K. Ruan, D.Y 2003) Effects of sodium valproate on synaptic plasticity in the CA1 region of rat hippocampus. Food Chem Toxicol 41, 1617 1623.
60. Zhang, Z., Hofmann, C., Casanova, E., Schutz, G. Lutz, B 2004) Generation of a conditional allele of the CBP gene in mouse. Genesis 40, 82 89.